These data may offer major benefits to patients and society, but current use is fragmented and suboptimal
We propose an integrated evidence based approach to data collection to meet multiple stakeholder needs
Over the past decade we have seen a global rise in the involvement of patients in coproducing research and decisions about their health and care. "Measuring what matters to patients" is recognised as central to improving patient care and service delivery, but patients need to be involved in deciding what to measure and how. 1 One way to measure what matters is using patient reported outcome measures (PROMs), which are questionnaires completed by patients to assess the effects of disease or treatment (or both) on symptoms, functioning, and health related quality of life from their perspective. PROM data can be used to inform health technology assessment, pharmaceutical labelling claims, health policy and service improvement, and can support communication between patients and healthcare professionals. 2 3 Here we discuss the current applications and potential benefits of PROMs in healthcare and challenges that reduce their potential to drive improvements in patient care. We focus on recent developments in the use of PROMs and consider strategies for efficient PROM data collection to maximise benefits for patients and society.
Current use and benefits
PROM assessment in research and routine clinical practice offers a range of potential benefits for individual patient care and for clinicians, regulators, healthcare management teams, commissioners, and policy makers (table 1).
The use of PROMs in research, particularly in clinical trials and observational studies, is well established and can provide valuable evidence on the burden of disease and the efficacy, effectiveness, and cost effectiveness of interventions from a patient perspective. 26 16 17 PROM data are increasingly being used to provide evidence for drug and device approval. Emphasis is being placed on involving patients throughout the innovation pathway, including the appropriate collection of PROMs informed by FDA and EMA guidance. 27 28 Aggregate PROM data have been used in routine practice for several years; for example, in the UK to assess provider performance in the primary care Quality and Outcomes Framework (QOF) 25 and in the NHS PROMs initiative. 2 29 Three PROMs (the PHQ9, HADS, and Beck Depression Inventory-II) were used as part of QOF to assess the severity of depression, to support clinical decision making, and to assess provider performance. However, the QOF indicator was dropped in 2013 owing to criticism regarding over-diagnosis using the tools and the potential for gaming. 25 30 PROMs have been used to measure health gain in patients undergoing hip or knee replacement, among other procedures, based on responses to questionnaires before and after surgery. Patients and referrers can use PROM data to help decide where to receive treatment: NHS Choices publishes provider level outlier data for PROM eligible procedures as part of a "score card." 31 The evidence to support using PROMs in 32 and challenges with paper based "top down" PROM capture include high rates of missing data and lack of accessible feedback for use by clinicians and patients. 29 By contrast, using PROMs at the individual patient level is relatively new. PROMs can be used to inform clinical decision aids, for shared decision making, and to tailor care to individual patient needs. Electronic capture of PROMs in clinic and between appointments allows real time monitoring of symptoms, flexible scheduling of hospital appointments in response to PROM data, early detection of problems, and prompt clinical intervention. 33 A US randomised trial of web based symptom monitoring in patients receiving chemotherapy showed that use of the tool was associated with better quality of life, fewer emergency hospital admissions, and increased survival. 8 9 In Denmark, the AmbuFlex telehealth system is being used to schedule outpatient appointments for chronic conditions, including asthma, chronic obstructive pulmonary disease, epilepsy, sleep apnoea, and cancer. 12 13 PROMs are completed by patients at home and used for decision support to evaluate the need for a consultation, reducing the need for unnecessary outpatient appointments. To date, 31 000 outpatients have been referred to AmbuFlex follow-up, and 115 000 telePRO based contacts have been completed.
Challenges to consider
Several challenges have hindered both uptake and benefit to patients of PROMs (box 1), with major problems found in PROM study design, implementation, reporting, and interpretation. 26 PROM data collection is fragmented, with limited coordination-if any-between teams responsible for research and routine care. Clinical disciplines often lack a standardised approach to assessment. Patients may be asked to complete multiple questionnaires, often with overlapping items, which can be burdensome and confusing. Furthermore, PROMs are often poorly or not reported, which limits their effects on patient care and is unethical. 29 38 Evidence shows that clinicians find that collecting PROMs improves clinical care and workflow and is "beneficial rather than burdensome." 4 But some clinicians think that these data are "subjective" and therefore biased or unimportant compared with laboratory findings. 
Ethical concerns
Patients may be unsure why they are being asked to complete a PROM, who will access their responses, and how the data will be used How the data will be used to maximise patient care has not always been fully considered, even in routine clinical practice 29 PROM data in research is commonly collected from a relatively small subset of the population, hindering wider applicability of findings. This may be more pronounced in trials with a "substudy" approach, or where appropriate, culturally validated, alternative language PROMs are not available
Missing data hinder reporting and use, and approaches to minimising missing data are highly variable 26 Lack of consensus regarding analytical approach 
Inefficient uncoordinated approach
Development in silos leads to duplication of effort and inconsistency in collection methods, measures used, and data collected Lack of integration between routine data collected for population level initiatives and individual symptom monitoring, and between routinely collected PROMs and research data Missed opportunity to upscale datasets and enhance efficiency; no opportunity to "collect once, use many times" 37 
Integrated approach to PROMs
We need a strategic, coordinated, integrated approach to PROM assessment, a view supported by international qualitative research. 39 This approach should be aimed at creating a non-burdensome pathway for patients to provide meaningful PROM data that may be used to support shared decision making, as well as provide a patient centred data pipeline for audit, benchmarking, research, and real world evidence (fig 1) . Routine remote PROM monitoring could be used to support not only patients at high risk of emergency admission but also the millions of people who have multiple long term health conditions to reduce unnecessary outpatient appointments, promote medicine adherence, and tailor care to individual needs. Beyond optimising healthcare resources, this approach offers broader benefits to patients and society, with potential reductions in time off work, carer burden, and carbon footprint.
Crucially, the same PROM data could be aggregated to inform commissioning and service delivery decisions. Concurrently, the data could be incorporated into pragmatic trials to provide real world evidence of effectiveness and safety. Large scale "PROmic" data could be integrated with genomic, proteomic, metabolomic, clinical, and biomarker data and be used in prognostic models to inform patients of likely courses of symptom burden and functioning. 40 Integrative approaches to PROM assessment should consider ways to reduce inefficiencies in data acquisition: a harmonised approach to the selection, collection, analysis, and reporting of PROMs, integration into the electronic health record, and guidance on the optimal presentation and use of data (fig 2) .
Stakeholder engagement and cooperation
A national PROM strategy should be developed with input from patients, clinicians, academics, industry, regulators, ethicists, and policy makers to ensure that the system and data meet stakeholder needs. We have found that engagement from patients, senior management, nurses, consultants, and allied healthcare professionals is essential to successful delivery of PROM specific strategic goals. 10 13 29 Establish which outcomes to measure PROMs should measure outcomes that correspond to stakeholder needs. Identifying these outcomes and what matters to patients should be a priority. Regulatory agencies may focus on physical symptoms and functioning to inform licensing and labelling claims, whereas patients and health policy makers may be more interested in other domains of health related quality of life, such as participation in social activities and emotional wellbeing. 41 Stakeholder relevant PROMs can be identified through patient involvement, qualitative research, or core outcome sets. These provide a set of standardised outcomes to be assessed in routine practice or effectiveness trials. They often include traditional clinical outcomes, such as all cause mortality, alongside measures of symptom burden, functioning, and disease control, which can be measured using PROMs. Several core outcome sets are available from the International Consortium for Health Outcomes Measurement 42 and the Core Outcome Measures in Effectiveness Trials initiative 43 ; further efficiencies may be gained, however, if a single core outcome set can be generated for research and routine practice for a clinical area or a broader set of conditions, such as inflammatory diseases.
Selection of PROMs
Identifying and selecting valid, reliable tools that are acceptable to patients from the target population may be challenging. The Consensus Based Standards for the Selection of Health Measurement Instruments initiative and the Evaluating the Measurement of Patient Reported Outcomes programme provide useful guidance to support the review of measurement properties. 44 45 Selected PROMs should have been developed with patient input, 27 but this is not the case for many commonly used measures. A further challenge is the use of different measurement scales, which make it difficult to compare across measures. The Patient Reported Outcomes Measurement Information System (PROMIS) aims to provide measures scored on a common scale across global, physical, mental, and social health domains. The PROMIS items can be used for computerised adaptive testing to reduce patient burden. 46 Further benefits of PROMs may be realised through individualised measures, but research in this area is scarce. 32 Ultimately, the utility of the measure may differ depending on context and purpose, but wherever possible systems should be designed with multiple use in mind.
Developing a governance framework
Patients need to know who will access their data and how their data will be used. Clearly this has important consent implications for integrative PROM collection, which must meet data protection regulations. PROM data may reveal worrying levels of psychological distress or physical symptoms that may require an immediate response, known as a "PRO alert." 34 Clear response pathways for the management of PRO alerts should be in place, and issues around legal liability for failure to act must be considered. Overarching guidance on governance would help implementation of PROMs and promote efficiency in delivery.
Integrated approach to electronic capture of PROMs
Health informatics systems should be developed to capture PROMs in a standardised way that will allow patients and clinicians to access data at the point of care, incorporating flexible permissions that allow the patient to choose how their data will be used. National institutes for data science in healthcare should play a pivotal role in infrastructure developments. Operational and logistical matters-such as patient identification, usability of the system by diverse patient groups, automated reminders, algorithms for PROM alert management, and reporting mechanisms-require careful consideration to encourage compliance, ensure smooth workflow, and promote data quality. To fully realise the benefits and to meet multiple stakeholder needs, PROM data should be aggregated with clinical and "omic" data; for example, to facilitate case mix adjustment for comparison of service providers and for use in prognostic models. 40 
Analysis, reporting, interpretation, and dissemination of PROM data
Data will need to be analysed and reported using different templates tailored to stakeholder needs. PROM data are currently presented in a wide range of formats and further research is needed to optimise their presentation for accurate interpretation of the data and to make it useful. 47 We have found that training and support is needed during early adoption.
System evaluation
Integrating PROM data will require iterative development and improvement. The cost effectiveness of PROM systems, impact on workflow and user satisfaction, and potential biases associated with multiple uses of data should be rigorously assessed. 48 
Conclusions
Routine collection, processing, and sharing of PROMs may offer huge benefits to society through better health outcomes and use of resources. There is clearly much to do to maximise the benefits of PROMs for patients and society. A crucial first step is to establish a national multi-stakeholder steering group, involving patients, clinicians, PROM methodologists, regulators, policy makers, and NHS digital to standardise PROM data and to establish and share knowledge and good practice. Integrated approaches to data collection will help promote optimal efficient collection, reduce patient burden, and enable us to harness patient centred data alongside health and biomedical outcomes to tackle healthcare challenges at scale. Greater collaborative multi-stakeholder efforts are required both nationally and internationally for the benefits of PROMs to be realised. A US study of outcomes reported by patients (n=2013) undergoing postmastectomy breast reconstruction using implant or autologous Inform shared decision making Tailor care to individual needs techniques assessed patient psychosocial and sexual wellbeing two years after surgery using the BREAST-Q PROM. Researchers found that patients who underwent autologous reconstruction were more satisfied and had greater wellbeing than those who chose implant reconstruction. 5 Research/routinely collected data in specific patient/population groups Patients/clinicians The improving access to psychological therapies (IAPT) programme has transformed treatment of adult anxiety disorders and depression in England. Over 900 000 people access IAPT services each year. The outcome monitoring system ensures that IAPT obtains symptom scores before and after treatment, which are used to inform treatment planning Patient/clinicians Remote symptom monitoring in patients receiving chemotherapy at Memorial Sloan Kettering Cancer Centre reduced emergency department admissions by 7%, hospital admissions by 4%, helped patients stay on treatment longer, improved patient quality of life by 31%, and increased survival on average by five months at low cost. 8 9 In the UK similar work is in development with current studies, for example, in chronic kidney disease and cancer 10 11 Facilitate early identification of problems and improve patient outcomes Allow rapid referral to specialist services when necessary
Currently not in widespread use in UK Patients/clinicians Ambuflex telePRO system, Denmark: see main text 12 13 Reduce unnecessary outpatient appointments for stable patients In the CARE-HF trial, PROM data were used to measure the effectiveness of cardiac resynchronisation, to assess the patient journey and longer term effects of treatment, and to inform cost effectiveness analyses and health technology appraisal 16 17 Understanding short and longer term effects of treatment http://www.bmj.com/
